{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -1.95, "sharesOutstanding": 2264960, "bookValue": 1.288, "fiftyDayAverage": 2.1704, "fiftyDayAverageChange": -1.4353999, "fiftyDayAverageChangePercent": -0.66135275, "twoHundredDayAverage": 7.47128, "twoHundredDayAverageChange": -6.73628, "twoHundredDayAverageChangePercent": -0.90162325, "marketCap": 2167471, "priceToBook": 0.5706522, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "GBP", "regularMarketOpen": 0.735, "averageDailyVolume3Month": 109, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.00999999, "fiftyTwoWeekLowChangePercent": 0.013793089, "fiftyTwoWeekRange": "0.725 - 53.0", "fiftyTwoWeekHighChange": -52.265, "fiftyTwoWeekHighChangePercent": -0.9861321, "fiftyTwoWeekLow": 0.725, "fiftyTwoWeekHigh": 53.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1645599600000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.00999999, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.735, "regularMarketDayRange": "0.735 - 0.735", "regularMarketDayLow": 0.735, "regularMarketVolume": 280, "regularMarketPreviousClose": 0.725, "bid": 0.77, "ask": 0.84, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": 1.3793089, "regularMarketPrice": 0.735, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "TC BIOPHARM(HLD.)SP.ADS/1", "longName": "TC Biopharm (Holdings) Plc", "messageBoardId": "finmb_1681274131", "market": "dr_market", "symbol": "T0U0.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://www.tcbiopharm.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan L. Kobel", "age": 41, "title": "CEO & Director", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Martin E. Thorp", "age": 70, "title": "CFO & Director", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Exec. VP of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Bree  Harlin", "title": "Chief Clinical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}